147 related articles for article (PubMed ID: 36143189)
1. Clustering Molecular Subtypes in Breast Cancer, Immunohistochemical Parameters and Risk of Axillary Nodal Involvement.
Pereira A; Siegrist J; Lizarraga S; Pérez-Medina T
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143189
[TBL] [Abstract][Full Text] [Related]
2. A Clinicopathological Analysis of Molecular Subtypes of Breast Cancer using Immunohistochemical Surrogates: A 6-Year Institutional Experience from a Tertiary Cancer Center in North India.
Somal PK; Sancheti S; Sharma A; Sali AP; Chaudhary D; Goel A; Dora TK; Brar R; Gulia A; Divatia J
South Asian J Cancer; 2023 Apr; 12(2):104-111. PubMed ID: 37969672
[TBL] [Abstract][Full Text] [Related]
3. Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery.
Houvenaeghel G; Cohen M; Martino M; Reyal F; Classe JM; Chauvet MP; Colombo PE; Heinemann M; Jouve E; Gimbergues P; Azuar AS; Coutant C; Gonçalves A; de Nonneville A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760536
[TBL] [Abstract][Full Text] [Related]
4. The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival.
Vasconcelos I; Hussainzada A; Berger S; Fietze E; Linke J; Siedentopf F; Schoenegg W
Breast; 2016 Oct; 29():181-5. PubMed ID: 27544822
[TBL] [Abstract][Full Text] [Related]
5. Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information.
Inic Z; Zegarac M; Inic M; Markovic I; Kozomara Z; Djurisic I; Inic I; Pupic G; Jancic S
Clin Med Insights Oncol; 2014; 8():107-11. PubMed ID: 25249766
[TBL] [Abstract][Full Text] [Related]
6. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort
Houvenaeghel G; de Nonneville A; Cohen M; Chopin N; Coutant C; Reyal F; Mazouni C; Gimbergues P; Azuar AS; Chauvet MP; Classe JM; Daraï E; Martinez A; Rouzier R; de Lara CT; Lambaudie E; Barrou J; Goncalves A
ESMO Open; 2021 Jun; 6(3):100151. PubMed ID: 33984674
[TBL] [Abstract][Full Text] [Related]
8. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
Falck AK; Fernö M; Bendahl PO; Rydén L
BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
[TBL] [Abstract][Full Text] [Related]
9. Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic Relevance.
Sali AP; Sharma N; Verma A; Beke A; Shet T; Patil A; Pai T; Nair N; Parmar V; Gupta S; Hawaldar R; Desai SB
Clin Breast Cancer; 2020 Oct; 20(5):382-389. PubMed ID: 32467058
[TBL] [Abstract][Full Text] [Related]
10. Association between molecular subtypes and lymph node status in invasive breast cancer.
Si C; Jin Y; Wang H; Zou Q
Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
[TBL] [Abstract][Full Text] [Related]
11. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.
Wong H; Lau S; Leung R; Chiu J; Cheung P; Wong TT; Liang R; Epstein RJ; Yau T
Med Oncol; 2012 Sep; 29(3):1536-42. PubMed ID: 21983862
[TBL] [Abstract][Full Text] [Related]
12. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.
Crabb SJ; Cheang MC; Leung S; Immonen T; Nielsen TO; Huntsman DD; Bajdik CD; Chia SK
Clin Breast Cancer; 2008 Jun; 8(3):249-56. PubMed ID: 18650155
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.
Kneubil MC; Brollo J; Botteri E; Curigliano G; Rotmensz N; Goldhirsch A; Lohsiriwat V; Manconi A; Martella S; Santillo B; Petit JY; Rietjens M
Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW
Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043
[TBL] [Abstract][Full Text] [Related]
15. Differences in clinicopathologic features and subtype distribution of invasive breast cancer between women older and younger than 40 years.
Ushimado K; Kobayashi N; Hikichi M; Tsukamoto T; Kuroda M; Utsumi T
Fujita Med J; 2019; 5(4):92-97. PubMed ID: 35111509
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer.
Munzone E; Bagnardi V; Rotmensz N; Sporchia A; Mazza M; Pruneri G; Intra M; Sciandivasci A; Gentilini O; Luini A; Viale G; Veronesi P; Colleoni M
Breast Cancer Res Treat; 2014 Aug; 146(3):573-82. PubMed ID: 25007961
[TBL] [Abstract][Full Text] [Related]
17. Axillary Staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden.
Lee MK; Montagna G; Pilewskie ML; Sevilimedu V; Morrow M
Ann Surg Oncol; 2023 Jan; 30(1):92-97. PubMed ID: 35876927
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the progesterone receptor status in Ki67-high and -low Luminal B-like HER2-negative breast cancers.
Sato K; Miyashita M; Ishida T; Suzuki A; Tada H; Watanabe G; Sato-Tadano A; Watanabe M; Ohuchi N
Breast Cancer; 2016 Mar; 23(2):310-7. PubMed ID: 25380989
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant Chemotherapy (NC) Response in Patients with Breast Cancer According to Immunohistochemical Intrinsic Subtypes (IHC)].
Ruvalcaba Limón E; Barreda Zelaya LE; García Orozco N; Morales Vásquez F; Bautista Piña V; Maffuz Aziz A; Rodríguez Cuevas S
Gac Med Mex; 2014 Dec; 150 Suppl 2():161-70. PubMed ID: 25643776
[TBL] [Abstract][Full Text] [Related]
20. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
